David Cendoya Revuelta

David Cendoya Revuelta is a Senior Consultant in Health Economics and Outcomes Research at Amaris Consulting, leading collaborations with top pharmaceutical companies to develop value-driven narratives and cost-effectiveness models, particularly in oncology. Previously, David worked as a Consultant at IQVIA, focusing on health economic evaluations across the EMEA region with an emphasis on engaging with NICE in the UK. Earlier experience includes roles as an Analyst at Boehringer Ingelheim and an intern in Market Access, contributing to the development of cost-effectiveness analyses and value materials for pharmaceutical products. David's educational background encompasses a Master’s degree in Health Economics from the University of Groningen, a qualification in Practical Modern Statistics from The Open University, and a Bachelor's degree in Economics from Universidad de Cantabria and Alma Mater Studiorum – Università di Bologna.